AC Immune S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACIU research report →
About the company
AC Immune S. A. is a biotech firm operating at the clinical stage, dedicated to pioneering, formulating, and advancing therapeutic agents and diagnostic tools.
- CEO
- Andrea Pfeifer
- IPO
- 2016
- Employees
- 133
- HQ
- Lausanne, CH
Price Chart
- Market Cap
- $255.45M
- P/E
- -3.05
- P/S
- 55.41
- P/B
- 6.31
- EV/EBITDA
- -2.95
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -1749.00%
- Net Margin
- -1788.79%
- ROE
- -123.98%
- ROIC
- -140.76%
- Revenue
- $3.57M · -86.92%
- Net Income
- $-70,447,000 · -38.36%
- EPS
- $-0.70 · -37.25%
- Op Income
- $-68,863,000
- FCF YoY
- -202.67%
- 52W High
- $4.00
- 52W Low
- $1.94
- 50D MA
- $2.66
- 200D MA
- $2.98
- Beta
- 1.56
- Avg Volume
- 297.71K
Get TickerSpark's AI analysis on ACIU
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 11, 26 | Twyman Roy Ervin | other | 16,568 |
| Jun 11, 26 | Twyman Roy Ervin | other | 38,889 |
| Jun 11, 26 | AGUIAR-LUCANDER RENEE | other | 16,568 |
| Jun 11, 26 | AGUIAR-LUCANDER RENEE | other | 38,889 |
| Jun 11, 26 | Zuegel Martin | other | 77,778 |
| Jun 11, 26 | Zuegel Martin | other | 33,136 |
| Jun 11, 26 | Buetler Monika | other | 17,751 |
| Jun 11, 26 | Buetler Monika | other | 41,667 |
| Jun 11, 26 | June Carl Howard | other | 16,568 |
| Jun 11, 26 | June Carl Howard | other | 38,889 |
Our ACIU coverage
Recent articles, reports, and earnings notes.
No research on ACIU yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ACIU report →Similar companies
Peers in the same neighborhood.